Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffery M Vance

Showing results (1-10 of 231) with videos related to

Pageof 24
Sort By:
Annals of the New York Academy of Sciences|November 1, 2017
Charcot-Marie-Tooth Disease Type 2Jeffery M Vance
Rinsho Shinkeigaku = Clinical Neurology|September 17, 2011
[Whole exome sequencing]Karen Nuytemans, Jeffery M Vance
Nature Clinical Practice. Neurology|August 26, 2006
Mechanisms of disease: a molecular genetic update on hereditary axonal neuropathiesStephan Züchner, Jeffery M Vance
Journal of Molecular Medicine (Berlin, Germany)|September 1, 2005
Emerging pathways for hereditary axonopathiesStephan Züchner, Jeffery M Vance
Neuromolecular Medicine|June 16, 2006
Molecular genetics of autosomal-dominant axonal Charcot-Marie-Tooth diseaseStephan Züchner, Jeffery M Vance
Continuum (Minneapolis, Minn.)|July 20, 2012
Genomic medicine and neurologyJeffery M Vance, Demet Tekin
Movement Disorders : Official Journal of the Movement Disorder Society|January 16, 2021
Gabapentin Relieves Vertigo of Periodic Vestibulocerebellar Ataxia: 3 Cases and Possible MechanismJ Thaddeus Coin, Jeffery M Vance
JAAPA : Official Journal of the American Academy of Physician Assistants|August 19, 2004
Alzheimer's disease genes and genetic testing in clinical practiceP C Gaskell, Jeffery M Vance
Movement Disorders : Official Journal of the Movement Disorder Society|August 19, 2021
Reply to: Gabapentin Relieves Vertigo of Periodic Vestibulocerebellar Ataxia: 3 Cases and Possible MechanismJ Thaddeus Coin, Jeffery M Vance
CNS & Neurological Disorders Drug Targets|May 16, 2012
Tyrosine hydroxylase gene: another piece of the genetic puzzle of Parkinson's diseaseGuney Bademci, Jeffery M Vance, Liyong Wang
Pageof 24

Showing results (1-10 of 231) with videos related to

Sort By:
Pageof 24
Annals of the New York Academy of Sciences|November 1, 2017
Charcot-Marie-Tooth Disease Type 2Jeffery M Vance
Rinsho Shinkeigaku = Clinical Neurology|September 17, 2011
[Whole exome sequencing]Karen Nuytemans, Jeffery M Vance
Nature Clinical Practice. Neurology|August 26, 2006
Mechanisms of disease: a molecular genetic update on hereditary axonal neuropathiesStephan Züchner, Jeffery M Vance
Journal of Molecular Medicine (Berlin, Germany)|September 1, 2005
Emerging pathways for hereditary axonopathiesStephan Züchner, Jeffery M Vance
Neuromolecular Medicine|June 16, 2006
Molecular genetics of autosomal-dominant axonal Charcot-Marie-Tooth diseaseStephan Züchner, Jeffery M Vance
Continuum (Minneapolis, Minn.)|July 20, 2012
Genomic medicine and neurologyJeffery M Vance, Demet Tekin
Movement Disorders : Official Journal of the Movement Disorder Society|January 16, 2021
Gabapentin Relieves Vertigo of Periodic Vestibulocerebellar Ataxia: 3 Cases and Possible MechanismJ Thaddeus Coin, Jeffery M Vance
JAAPA : Official Journal of the American Academy of Physician Assistants|August 19, 2004
Alzheimer's disease genes and genetic testing in clinical practiceP C Gaskell, Jeffery M Vance
Movement Disorders : Official Journal of the Movement Disorder Society|August 19, 2021
Reply to: Gabapentin Relieves Vertigo of Periodic Vestibulocerebellar Ataxia: 3 Cases and Possible MechanismJ Thaddeus Coin, Jeffery M Vance
CNS & Neurological Disorders Drug Targets|May 16, 2012
Tyrosine hydroxylase gene: another piece of the genetic puzzle of Parkinson's diseaseGuney Bademci, Jeffery M Vance, Liyong Wang
Pageof 24